Abbott India Limited (BOM:500488)
India · Delayed Price · Currency is INR 26,155
+86 (0.33%)
At close: Oct 16, 2026
Abbott India Market Cap
Abbott India has a market cap or net worth of 555.77 billion as of October 16, 2026. It is the 3,230th most valuable company in the world and the 191st biggest in India. Its market cap has decreased by 12.17% in one year.
Market Cap
555.77B
Enterprise Value
535.17B
Revenue
70.04B
Global Rank
Country Rank
#191 India
PE Ratio
34.42
ChartMarket Cap Chart
Since February 21, 2002, Abbott India's market cap has increased from 4.77B to 555.77B, an increase of 11,553.17%. That is a compound annual growth rate of 21.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 555.77B | -10.03% |
| Dec 31, 2025 | 617.71B | -2.27% |
| Dec 31, 2024 | 632.08B | 30.17% |
| Dec 29, 2023 | 485.60B | 6.63% |
| Dec 30, 2022 | 455.40B | 10.06% |
| Dec 31, 2021 | 413.77B | 23.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.75T |
| Dr. Reddy's Laboratories | 1.02T |
| Lupin | 895.81B |
| GlaxoSmithKline Pharmaceuticals | 427.41B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Granules India | 201.45B |
| Caplin Point Laboratories | 175.06B |
| Jubilant Pharmova | 148.59B |